Kymera Therapeutics Files 8-K
Ticker: KYMR · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1815442
| Field | Detail |
|---|---|
| Company | Kymera Therapeutics, Inc. (KYMR) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Kymera filed an 8-K on 6/2/25 covering various corporate events and financials.
AI Summary
Kymera Therapeutics, Inc. filed an 8-K on June 2, 2025, reporting on events including Regulation FD disclosures, other events, and financial statements. The company, incorporated in Delaware, is based in Watertown, Massachusetts, and operates in the biological products sector.
Why It Matters
This filing provides an update on Kymera Therapeutics' corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports on significant corporate events or financial updates without immediate market-moving news.
Key Numbers
- 0001815442 — Central Index Key (Unique identifier for the filer)
- 812992166 — EIN (Employer Identification Number)
Key Players & Entities
- Kymera Therapeutics, Inc. (company) — Registrant
- June 2, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Watertown, Massachusetts (location) — Principal executive offices
- 001-39460 (other) — SEC File Number
FAQ
What specific events are detailed in this 8-K filing?
The filing indicates it covers Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this 8-K?
The earliest event reported was on June 2, 2025.
What is Kymera Therapeutics' principal executive office address?
The principal executive offices are located at 500 North Beacon Street, 4th Floor, Watertown, Massachusetts 02472.
What is Kymera Therapeutics' industry classification?
The company is classified under Biological Products (No Diagnostic Substances) [2836].
What is the SEC File Number for Kymera Therapeutics?
The SEC File Number is 001-39460.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Kymera Therapeutics, Inc. (KYMR).